186 related articles for article (PubMed ID: 12850623)
1. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?
Chan JK; Loizzi V; Lin YG; Osann K; Brewster WR; DiSaia PJ
Obstet Gynecol; 2003 Jul; 102(1):156-61. PubMed ID: 12850623
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors of epithelial ovarian cancer in young women].
Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
[TBL] [Abstract][Full Text] [Related]
3. Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer.
Prat A; Parera M; Peralta S; Perez-Benavente MA; Garcia A; Gil-Moreno A; Martinez-Palones JM; Roxana I; Baselga J; Del Campo JM
Ann Oncol; 2008 Feb; 19(2):327-31. PubMed ID: 18065408
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer.
Cress RD; Chen YS; Morris CR; Petersen M; Leiserowitz GS
Obstet Gynecol; 2015 Sep; 126(3):491-497. PubMed ID: 26244529
[TBL] [Abstract][Full Text] [Related]
6. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
Timmermans M; Sonke GS; Van de Vijver KK; van der Aa MA; Kruitwagen RFPM
Eur J Cancer; 2018 Jan; 88():31-37. PubMed ID: 29179135
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.
Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY
Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
Wu M; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
10. Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
Solmaz U; Mat E; Dereli ML; Turan V; Peker N; Tosun G; Dogan A; Adiyeke M; Ozdemir A; Gungorduk K; Sanci M; Yildirim Y
J BUON; 2015; 20(3):847-54. PubMed ID: 26214639
[TBL] [Abstract][Full Text] [Related]
11. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
Gockley A; Melamed A; Bregar AJ; Clemmer JT; Birrer M; Schorge JO; Del Carmen MG; Rauh-Hain JA
Obstet Gynecol; 2017 Mar; 129(3):439-447. PubMed ID: 28178043
[TBL] [Abstract][Full Text] [Related]
13. The effect of centralization of primary surgery on survival in ovarian cancer patients.
Tingulstad S; Skjeldestad FE; Hagen B
Obstet Gynecol; 2003 Sep; 102(3):499-505. PubMed ID: 12962932
[TBL] [Abstract][Full Text] [Related]
14. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
[TBL] [Abstract][Full Text] [Related]
15. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
18. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
Wong KH; Mang OW; Au KH; Law SC
Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
[TBL] [Abstract][Full Text] [Related]
19. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
